Background:
Rational use of medicines plays a vital role in avoiding preventable adverse drug effects, maximizing therapeutic outcomes with promoting patient adherence, and minimizing the cost of drug therapy. Irrational use of drugs is often observed in countries with weak health care systems. No review has been done that systematically expresses rational drug use practice based on the three WHO core drug use indicators in Ethiopia. Thus, this study was aimed to review systematically the prescribing, health-facility, and patient-care indicators based on WHO core drug use indicators in Ethiopia.
Methods:
A systematic article search was conducted in different electronic databases including PubMed/ MEDLINE, the Cochrane Library, EMBASE, Web of Science, POPLINE, the Global Health, and Google scholar. Quality assessment was conducted using Newcastle-Ottawa quality assessment scale. Studies were synthesized and grouped in to prescribing, patient care and health facility indicators.
Results:
From a total of 6239 articles, 21 studies were found suitable for the review. The highest average number of drugs per encounter was 2.5 while the lowest was 0.98. The percentage of generic drug use was ranged from 70.5% to 100%. The highest percentage of encounters with an antibiotic was 85%. The lowest percentage of drugs prescribed from essential drugs list was 81.4%. The highest percentage of drugs actually dispensed and adequately labeled was 96.16% and 96.25%, respectively.
Conclusion:
This study showed that the practice of rational drug use varied across region of the country. The average number of drugs per prescription, percentage of drugs encounter with antibiotics, drugs prescribed by their generic name, average consultation time, average dispensing time, percentage of drugs adequately labeled, and availability of essential drugs showed deviation from the standard recommended by WHO. Thus, provision of regular training for prescribers and pharmacists, and ensuring the availability of essential drugs should be encouraged.
Citing Articles
Design and Evaluation of ACAFiB-APP, a clinical decision support system for anticoagulant considerations in patients with atrial fibrillation.
Ansari R, Rezayi S, Safaei A, Mollazadeh R, Rezaei E, Mafinejad M
BMC Cardiovasc Disord. 2025; 25(1):166.
PMID: 40057691
PMC: 11889798.
DOI: 10.1186/s12872-025-04615-w.
Drug prescription patterns and compliance with WHO and beers criteria in older patients.
Malekzadeh M, Khadivi Y, Sohrevardi S, Afzal G
BMC Geriatr. 2025; 25(1):135.
PMID: 40016640
PMC: 11866591.
DOI: 10.1186/s12877-025-05780-5.
Irrational medicine use and its associated factors in conflict-affected areas in Mali: a cross-sectional study.
Ahmed M, Seydou A, Coulibaly I, Kielmann K, Ravinetto R
Glob Health Action. 2025; 18(1):2458935.
PMID: 39907053
PMC: 11800337.
DOI: 10.1080/16549716.2025.2458935.
Minimising inhaled corticosteroids for COPD.
Heran B, Perry T, Bassett K
Afr J Prim Health Care Fam Med. 2025; 16(1):e1-e3.
PMID: 39846112
PMC: 11736534.
DOI: 10.4102/phcfm.v16i1.4756.
Assessment of knowledge and perception of prescribers towards rational medicine use in the Ashanti Region of Ghana.
Djochie R, Owusu-Donkor R, dAlmeida E, Gyamfi Akwah F, Kyeremateng E, Opoku-Afriyie S
PLoS One. 2024; 19(10):e0308406.
PMID: 39480833
PMC: 11527319.
DOI: 10.1371/journal.pone.0308406.
Evaluation of a short-structured learner-centric training program on rational drug prescribing for medical interns: A quasi-experimental study.
Nishanthi A, Mahendran R, Ganapathy K, Shanthi M
J Family Med Prim Care. 2024; 13(8):3231-3237.
PMID: 39228589
PMC: 11368342.
DOI: 10.4103/jfmpc.jfmpc_129_24.
Drug Use Evaluation of Tenofovir/Lamivudine/Dolutegravir (TLD) Fixed-Dose Combination for Initiation and Transition Among HIV-Infected Individuals Attending Lumame Primary Hospital, North West Ethiopia.
Tegegne B, Alehegn A, Kassahun M
Integr Pharm Res Pract. 2024; 13:31-42.
PMID: 38650710
PMC: 11034558.
DOI: 10.2147/IPRP.S455351.
Evaluation of Rational Medicines Use Based on World Health Organization Core Indicators: A Cross-Sectional Study in Five Health Districts in Mauritania.
Ahmed M, Ravinetto R, Diop K, Trasancos Buitrago V, Dujardin C
Integr Pharm Res Pract. 2024; 13:17-29.
PMID: 38566890
PMC: 10984847.
DOI: 10.2147/IPRP.S447664.
Drug information-seeking behaviour among Jordanian physicians: a cross-sectional study.
Al Zoubi S, Gharaibeh L, Amaireh E, Khlaifat G, Khalayla H, Obeid S
Front Pharmacol. 2023; 14:1264794.
PMID: 38026931
PMC: 10679432.
DOI: 10.3389/fphar.2023.1264794.
Epidemiological study of antimicrobial-resistant bacteria in healthy free-ranging bantengs () and domestic cattle.
Konputtar A, Yossapol M, Phaechaiyaphum T, Manyuen P, Suetrong N, Ruksachat N
Vet World. 2023; 16(9):1796-1802.
PMID: 37859948
PMC: 10583867.
DOI: 10.14202/vetworld.2023.1796-1802.
Investigating the relationship between consultation length and quality of tele-dermatology E-consults in China: a cross-sectional standardized patient study.
Gong X, Hou M, Guo R, Feng X
BMC Health Serv Res. 2022; 22(1):1187.
PMID: 36138410
PMC: 9493166.
DOI: 10.1186/s12913-022-08566-2.
Theoretical model and measurement of shared decision making in web-based pharmaceutical care consultation.
Chen H, Xiong Y, Zhang Z, Zhou Q, Wang D, Wang X
Digit Health. 2022; 8:20552076221089794.
PMID: 35402000
PMC: 8984866.
DOI: 10.1177/20552076221089794.
Systematic review and meta-analysis of medicine use studies in Ethiopia using the WHO patient care indicators with an emphasis on the availability of prescribed medicines.
Teni F, Wubishet B, Yimenu D
BMJ Open. 2022; 12(3):e054521.
PMID: 35314470
PMC: 8938701.
DOI: 10.1136/bmjopen-2021-054521.
[Indicators of rational prescription of medicines: feasibility of application in institutions in the AmericasIndicadores de prescrição racional de medicamentos: viabilidade de aplicação em instituições das Américas].
Dorati C, Mordujovich Buschiazzo P, Marin G, Buschiazzo H, Rojas-Cortes R, Alfonso Arvez M
Rev Panam Salud Publica. 2022; 45:e152.
PMID: 34987559
PMC: 8699123.
DOI: 10.26633/RPSP.2021.152.
The Pattern of Medicine Use in Ethiopia Using the WHO Core Drug Use Indicators.
Mohammed S, Faris A
Biomed Res Int. 2022; 2021:7041926.
PMID: 34980999
PMC: 8720245.
DOI: 10.1155/2021/7041926.